000 01741 a2200457 4500
005 20250516213213.0
264 0 _c20150420
008 201504s 0 0 eng d
022 _a1531-8257
024 7 _a10.1002/mds.25909
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMahmoudi, Souha
245 0 0 _aUpregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.
_h[electronic resource]
260 _bMovement disorders : official journal of the Movement Disorder Society
_cAug 2014
300 _a1125-33 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntipsychotic Agents
_xpharmacology
650 0 4 _aBrain
_xdrug effects
650 0 4 _aCebus
650 0 4 _aClozapine
_xpharmacology
650 0 4 _aDisease Models, Animal
650 0 4 _aDopamine Antagonists
_xtoxicity
650 0 4 _aEnkephalins
_xgenetics
650 0 4 _aFemale
650 0 4 _aHaloperidol
_xtoxicity
650 0 4 _aIodine Radioisotopes
_xpharmacokinetics
650 0 4 _aMovement Disorders
_xetiology
650 0 4 _aNeurons
_xdrug effects
650 0 4 _aOvariectomy
650 0 4 _aProtein Binding
_xdrug effects
650 0 4 _aReceptors, Dopamine D2
_xgenetics
650 0 4 _aReceptors, Dopamine D3
_xgenetics
650 0 4 _aSulpiride
_xanalogs & derivatives
650 0 4 _aTetrahydronaphthalenes
_xpharmacokinetics
650 0 4 _aUp-Regulation
_xdrug effects
700 1 _aLévesque, Daniel
700 1 _aBlanchet, Pierre J
773 0 _tMovement disorders : official journal of the Movement Disorder Society
_gvol. 29
_gno. 9
_gp. 1125-33
856 4 0 _uhttps://doi.org/10.1002/mds.25909
_zAvailable from publisher's website
999 _c23835200
_d23835200